Strategic Expansion UCB’s significant investments in expanding biopharmaceutical facilities in Switzerland and the United States indicate ongoing growth and increased manufacturing capacity, presenting opportunities to supply advanced manufacturing equipment, logistical support, and modular systems to support their new facilities and regional operations.

Sustainability Recognition UCB has been recognized as one of the world's most sustainable companies with high scores from CDP and ranking among top global sustainability lists, creating potential for collaborations in eco-friendly packaging, green supply chain solutions, and corporate social responsibility initiatives.

Technology Adoption Utilizing advanced tech stacks such as SAP ERP, Veeva Systems, and Brandwatch, UCB emphasizes digital transformation, offering opportunity to provide integrated digital solutions, cloud services, and data analytics platforms to optimize their R&D, manufacturing, and marketing processes.

Financial Growth Potential With recent substantial investments, including a $5 billion factory in the US and over CHF 100 million in Swiss assets, UCB’s expanding capital expenditure indicates readiness for partnerships in construction, infrastructure development, and specialized manufacturing supplies.

Workforce Expansion UCB plans to add hundreds of jobs in new facilities, demonstrating a commitment to scaling operations; this unlocks opportunities for staffing solutions, training services, and HR technology providers to support their talent acquisition and employee engagement efforts.